qXR-CTR vs Viz RV/LV

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Qure.ai
VS
by Viz.ai

AI Verdict

While both tools leverage AI for cardiac imaging analysis, their direct comparability is limited by their distinct imaging modalities and clinical applications. qXR-CTR focuses on cardiothoracic ratio from chest X-rays for general heart size assessment, whereas Viz RV/LV analyzes CTPA scans for RV/LV ratios to stratify pulmonary embolism risk.

Choose qXR-CTR if…

Choose qXR-CTR if your primary need is automated, efficient screening for enlarged heart size and potential heart failure risk using standard chest X-ray images. This tool is ideal for high-volume settings where rapid, AI-powered assessment of the cardiothoracic ratio can support early identification of cardiac abnormalities.

View qXR-CTR →

Choose Viz RV/LV if…

Choose Viz RV/LV if you require rapid, AI-driven assessment of right and left ventricular diameters from CTPA scans specifically for pulmonary embolism risk stratification. This solution is best suited for emergency medicine and pulmonology departments needing immediate insights into PE severity and integrated care team coordination.

View Viz RV/LV →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature qXR-CTR Viz RV/LV
Deployment Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. Cloud-based
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz RV/LV

Viz RV/LV (Tool B) offers a more comprehensive and integrated user experience by providing annotated images, AI-powered alerts, a high-fidelity mobile DICOM image viewer, and a HIPAA-compliant communication platform as part of its broader PE solution. While qXR-CTR (Tool A) provides reports and has an app with workflow features, Tool B's emphasis on real-time alerts and care team communication for acute conditions suggests a more dynamic and collaborative user experience.

Clinical Value

Viz RV/LV

Both tools offer significant clinical value in their respective domains. However, Viz RV/LV (Tool B) focuses on rapid pulmonary embolism risk stratification and care coordination for a time-sensitive, life-threatening condition, with evidence suggesting it improves outcomes and saves lives through expedited decision-making. While qXR-CTR (Tool A) is valuable for heart failure risk assessment, Tool B's direct impact on acute patient management gives it a slight edge in immediate, high-impact clinical value.

Pricing & Value

Tie

Both qXR-CTR (Tool A) and Viz RV/LV (Tool B) do not publicly disclose their pricing, making a direct comparison on cost impossible. While both offer value through automated measurements and improved diagnostic efficiency, without transparent pricing, it is not possible to definitively determine which offers superior overall value.

Enterprise Readiness

Viz RV/LV

Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, demonstrating foundational enterprise readiness. While qXR-CTR (Tool A) offers more flexible deployment options (cloud, on-premise, hybrid), Viz RV/LV (Tool B) demonstrates superior enterprise readiness through its proven widespread adoption across over 1,200 health systems and comprehensive security certifications (SOC 2, ISO) available via its Trust Center.

Innovation

Viz RV/LV

Both tools leverage AI for innovative medical imaging analysis. However, Viz RV/LV (Tool B) extends its innovation beyond just measurement by integrating into a comprehensive care coordination platform with AI-powered alerts, mobile viewing, and communication tools. This holistic approach to streamlining the entire care pathway for acute conditions offers a broader and more transformative impact on healthcare delivery compared to qXR-CTR's (Tool A) focus on automated measurement.

Support & Docs

Viz RV/LV

Both companies offer comprehensive support and documentation. However, Viz RV/LV (Tool B) explicitly provides 24/7/365 urgent phone support in the USA, which is crucial for critical healthcare environments. Qure.ai (Tool A) offers a dedicated client success partner, email support with a typical 6-hour response time, and a HelpCenter, which is robust but less immediate than 24/7 phone support.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature qXR-CTR Viz RV/LV
Tool Name qXR-CTR Viz RV/LV
Company Qure.ai Technologies Viz.ai
Primary Function Automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. Automates right and left ventricular diameter measurements from CTPA scans, providing a crucial RV/LV ratio for rapid pulmonary embolism risk stratification and enhanced care coordination.
Target Modality Chest X-ray images CTPA scans
Key Measurement/Ratio Cardiothoracic Ratio (CTR) Right Ventricle (RV) to Left Ventricle (LV) ratio

Videos

Demos, reviews, and walkthroughs featuring qXR-CTR and Viz RV/LV.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

qXR-CTR is designed to automate the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. Viz RV/LV automates right and left ventricular diameter measurements from CTPA scans to provide a crucial RV/LV ratio for rapid pulmonary embolism risk stratification.
qXR-CTR processes chest X-ray images to calculate the cardiothoracic ratio. In contrast, Viz RV/LV analyzes volumetric CTPA acquisitions to determine right and left ventricular diameters.
qXR-CTR provides an automated measurement of the cardiothoracic ratio (CTR). Viz RV/LV calculates the right ventricle (RV) to left ventricle (LV) diameter ratio.
While qXR-CTR focuses on assessment, Viz RV/LV is a seamless component of the Viz PE Solution, offering AI-powered alerts, notifications to care teams, a mobile DICOM image viewer, and a HIPAA-compliant communication platform for enhanced care coordination. This integration supports a more comprehensive workflow for suspected pulmonary embolism detection.
qXR-CTR is primarily aimed at Cardiology and Radiology specialties. Viz RV/LV targets Emergency Medicine, Pulmonology, and Radiology, especially within the context of pulmonary embolism management.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.